Please login to the form below

Not currently logged in
Email:
Password:

Just:: Health Communications becomes HAVAS Just::

Healthcare agency changes name one year after its acquisition by HAVAS Health

Havas JustJust:: Health Communications has changed its name to HAVAS Just:: following its acquisition by the HAVAS Health group in June last year.

The London-based agency became part of HAVAS to expand its global reach and tap into the group's in-market knowledge and expertise.

Lead by co-founders Emma Crozier and Jennie Talman, HAVAS Just:: continues to be managed by its existing senior team and reports to HAVAS Health's chief executive Donna Murphy.

The acquisition of Just:: was a “strategic investment in the PR space to further grow the HAVAS Health brand footprint in global markets”, according to Murphy.

She added that the past 12 months have been a success for the group, and has unified the network's “unique” approach to healthcare communications.

Commenting on the name change, Talman said: “We are proud to be part of HAVAS Health.

“We share the same passion and enthusiasm for the work and after a successful 12 months we are delighted to embrace HAVAS not only in spirit but also in name.”

Article by
Rebecca Clifford

1st July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

WHITE PAPER 05: Improving the effectiveness of clinical trial recruitment materials
With exclusive research conducted by COUCH Health, gain insight into clinical trial recruitment materials best practice....
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...

Infographics